HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia.

Abstract
Oleoylethanolamide (OEA) has been shown to have neuroprotective effects after acute cerebral ischemic injury. The aim of this study was to investigate the effects of chronic OEA treatment on ischemia-induced spatial cognitive impairments, electrophysiology behavior and hippocampal neurogenesis. Daily treatments of 30 mg/kg OEA significantly ameliorated spatial cognitive deficits and attenuated the inhibition of long-term potentiation (LTP) in the middle cerebral artery occlusion (MCAO) rat model. Moreover, OEA administration improved cognitive function in a manner associated with enhanced neurogenesis in the hippocampus. Further study demonstrated that treatment with OEA markedly increased the expressions of brain-derived neurotrophic factor (BDNF) and peroxisome proliferator-activated receptors α (PPARα). Our data suggest that chronic OEA treatment can exert functional recovery of cognitive impairments and neuroprotective effects against cerebral ischemic insult in rats via triggering of neurogenesis in the hippocampus, which supports the therapeutic use of OEA for cerebral ischemia.
AuthorsLi-Chao Yang, Han Guo, Hao Zhou, Da-Qin Suo, Wen-Jun Li, Yu Zhou, Yun Zhao, Wu-Shuang Yang, Xin Jin
JournalBiochemical pharmacology (Biochem Pharmacol) Vol. 94 Issue 4 Pg. 270-81 (Apr 15 2015) ISSN: 1873-2968 [Electronic] England
PMID25748831 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Brain-Derived Neurotrophic Factor
  • Endocannabinoids
  • Oleic Acids
  • PPAR alpha
  • oleoylethanolamide
Topics
  • Animals
  • Brain-Derived Neurotrophic Factor (metabolism)
  • Cognition Disorders (drug therapy, psychology)
  • Dentate Gyrus (drug effects, physiopathology)
  • Endocannabinoids
  • Hippocampus (drug effects, pathology, physiopathology)
  • Ischemic Attack, Transient (drug therapy, pathology, physiopathology, psychology)
  • Long-Term Potentiation (drug effects)
  • Male
  • Maze Learning (drug effects)
  • Neurogenesis
  • Neuroglia (drug effects, pathology)
  • Neurons (drug effects, pathology)
  • Oleic Acids (pharmacology, therapeutic use)
  • PPAR alpha (metabolism)
  • Rats, Sprague-Dawley
  • Spatial Learning (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: